Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisemed Hangzhou Meditech CoBJSE:920069 18 Gross Margin % is 52.58% as of Jun. 2026, which is 9% above its 10-year median of 48.32. GuruFocus rates BJSE:920069 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 805 Medical Devices & Instruments companies, Promisemed Hangzhou Meditech Co ranks worse than 88.7% on this metric.
BJSE:920069's Gross Margin % is ranked worse than 88.7% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.41
vs BJSE:920069: 21.60
Promisemed Hangzhou Meditech Co had a gross margin of 52.58% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Promisemed Hangzhou Meditech Co (BJSE:920069) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Promisemed Hangzhou Meditech Co had a gross margin of 52.58% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Promisemed Hangzhou Meditech Co Gross Margin % Related Terms
Promisemed Hangzhou Meditech Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisemed Hangzhou Meditech Co Gross Margin % Chart
BJSE:920069 vs ISRG, BDX, RMD: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Promisemed Hangzhou Meditech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisemed Hangzhou Meditech Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Promisemed Hangzhou Meditech Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Promisemed Hangzhou Meditech Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Promisemed Hangzhou Meditech Co (BJSE:920069) has a Gross Margin % of 52.58% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Promisemed Hangzhou Meditech Co and its competitors. This is near median its historical median of 48.32. Over the past decade, Promisemed Hangzhou Meditech Co's Gross Margin % has ranged from 21.60 to 52.03. According to the industry distribution chart, Promisemed Hangzhou Meditech Co ranks #714 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 88.7%.
Is Promisemed Hangzhou Meditech Co's Gross Margin % too high?
Promisemed Hangzhou Meditech Co's current Gross Margin % of 52.58% is near median its 10-year median of 48.32. Over the past 10 years, this metric has ranged from a low of 21.60 to a high of 52.03. The Medical Devices & Instruments industry median Gross Margin % is 52.41. Promisemed Hangzhou Meditech Co's value of 52.58% is 0.3% above this industry median. Based on the distribution chart, Promisemed Hangzhou Meditech Co ranks #714 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Promisemed Hangzhou Meditech Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Promisemed Hangzhou Meditech Co's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Promisemed Hangzhou Meditech Co ranks #714 out of 805 companies for Gross Margin %. This places Promisemed Hangzhou Meditech Co in the lower half of its industry. The industry median Gross Margin % is 52.41. Promisemed Hangzhou Meditech Co's value of 52.58% is 0.3% above this benchmark. Historically, Promisemed Hangzhou Meditech Co's own Gross Margin % has ranged from 21.60 to 52.03 over the past decade. While the company's 10-year median is 48.32 vs. the industry median of 52.41, Promisemed Hangzhou Meditech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.41, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisemed Hangzhou Meditech Co's current Gross Margin % of 52.58% is 0.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Promisemed Hangzhou Meditech Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisemed Hangzhou Meditech Co's current Gross Margin % is 52.58%, which is near median its own 10-year median of 48.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisemed Hangzhou Meditech Co stock overvalued right now?
Promisemed Hangzhou Meditech Co (BJSE:920069) has a current Gross Margin % of 52.58%. The current Gross Margin % is 52.58%, which is near median its 10-year median of 48.32 and 0.3% above the Medical Devices & Instruments industry median of 52.41. Promisemed Hangzhou Meditech Co's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Promisemed Hangzhou Meditech Co (BJSE:920069), the current Gross Margin % is 52.58% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Promisemed Hangzhou Meditech Co Ltd is engaged in the Research, development, production and sales of diabetes care, universal drug delivery and infusion, and minimally invasive interventional medical devices.
18GF Score
Get the complete analysis for BJSE:920069
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920069 has been successfully added to your 
